The Lancet Rheumatology Impact Factor, Indexing, Ranking 2024

The Lancet Rheumatology is committed to publishing content relevant to rheumatology specialists worldwide, with a focus on studies that advance clinical practice, challenge the status quo, and advocate change in health policy. With a strong clinical focus, we provide an independent voice for the rheumatology community and advocate strongly for the improved lives of patients with rheumatic diseases around the globe.We publish clinical research (with an emphasis on clinical trials), expert reviews, and provocative comment and opinion relating to the diagnosis and classification, management, and prevention of rheumatic diseases, including arthritic, musculoskeletal, and connective tissue diseases, as well as disorders of the immune system. We also publish high-quality human translational studies that are supported by robust clinical data, with priority given to studies that identify potential new therapeutic targets, advance efforts toward precision medicine, or have the potential to directly inform future clinical trials

《柳叶刀风湿病学》致力于发表对全球风湿病学专家具有相关性的内容，聚焦于推进临床实践、挑战现状并倡导健康政策变革的研究。本刊以严谨的临床研究为核心，为风湿病学界提供独立的声音，并积极倡导全球范围内风湿性疾病患者的生命质量提升。我们发表的临床研究（特别强调临床试验）、专家综述以及有关风湿性疾病的诊断与分类、治疗与预防，包括关节炎、肌肉骨骼疾病和结缔组织疾病，以及免疫系统疾病的相关评论和观点。此外，我们还发表高质量的人体转化研究，这些研究基于稳健的临床数据支持，优先考虑那些识别潜在新治疗靶点、推进精准医学努力或有可能直接指导未来临床试验的研究。